首页|安全性视角下基本药物制度评价模型构建及效果评价

安全性视角下基本药物制度评价模型构建及效果评价

扫码查看
目的 构建安全性视角下基本药物制度评价模型,为基本药物安全性管理提供参考。方法 通过德尔菲法和层次分析法确定各级指标和权重,构建安全性评价模型。利用中国上市药品目录集、《中国药典》等收集基本药物(2018 年)安全性指标数据。运用李克特量表法对实证数据进行评分,将评分值输入构建的模型中,获得安全性视角下基本药物制度的效果评价分值。结果 构建模型的 5 个一级指标(准则层)的权重分别为0。261,0。189,0。431,0。075,0。083,10 个二级指标(指标层)的权重分别为 0。504,0。496,0。433,0。567,0。429,0。571,1。000,0。252,0。551,0。196。运用该模型对基本药物进行实证评估,综合评价总得分为 3。684 分,综合评价为73。68%。结论 构建的模型稳定可靠、具有可行性,能全面反映基本药物的安全性,现行基本药物的安全管理需进一步完善。
Construction and Effectiveness Evaluation of the Evaluation Model of Essential Drug System from the Perspective of Safety
Objective To construct an evaluation model of the essential drug system from the perspective of safety,and to provide a reference for the safety management of essential drugs.Methods The Delphi method combined with the Analytic Hierarchy Process(AHP)was used to determine the indicators and weights at all levels of the model,and to construct the safety evaluation model.The safety index data of essential drugs(2018)in China were collected by using the China Listed Drug Catalogue and the Chinese Pharmacopoeia.The empirical data were scored by the Likert scale method,and the rating value was input into the model to obtain the evaluation scores of the implementation effect of the national essential drugs system from the perspective of safety.Results The weights of the five first-level indicators(criterion layer)of the constructed evaluation model were 0.261,0.189,0.431,0.075,and 0.083,respectively.The weights of the ten second-level indicators(index layer)of the constructed evaluation model were 0.504,0.496,0.433,0.567,0.429,0.571,1.000,0.252,0.551,and 0.196,respectively.The model was used to empirically evaluate the safety of the essential drugs,with a total score of 3.684 points and a comprehensive evaluation of 73.68%.Conclusion The constructed model is stable,reliable,and feasible,which can comprehensively reflect the safety of essential drugs.The current safety management of essential drugs needs to be further improved.

national essential drug systemsafetyevaluation index systemAnalytic Hierarchy ProcessDelphi method

唐婉、陈红斗、张子歆、尤正仪、林彦全

展开 >

徐州医科大学附属宿迁医院·南京鼓楼医院集团宿迁医院,江苏 宿迁 223800

徐州医科大学,江苏 徐州 221000

国家基本药物制度 安全性 评价指标体系 层次分析法 德尔菲法

江苏省宿迁市"333高层次人才培养工程"科研项目(第五期)江苏省药学会-天晴医院药学基金科研项目

BRA2020234Q202043

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(7)
  • 18